NASDAQ:PPCB | Free Cash Flow | Propanc Biopharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-06-30 to 2025-09-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$1.94M$2,491.00-$1.94M
2025-06-30-$92,186.00
2024-09-30-$235,515.00
2024-06-30-$259,966.00
2023-09-30-$333,457.00
2023-06-30-$177,973.00
2022-09-30-$509,315.00
2022-06-30-$410,998.00
2021-09-30-$486,758.00
2021-06-30-$236,287.00
2020-09-30-$179,949.00
2020-06-30-$499,658.00
2019-09-30-$726,331.00
2019-06-30-$266,232.00$0.00-$266,232.00
2018-09-30-$419,196.00
2018-06-30-$447,560.00
2017-09-30-$785,668.00
2017-06-30-$601,556.00
2016-09-30-$683,598.00$0.00-$683,598.00
2016-06-30-$2.3M$9,203.00-$2.31M
2015-09-30-$405,712.00$679.00-$406,391.00
2015-06-30-$728,938.00$2,983.00-$731,921.00
2014-09-30$99,811.00$0.00$99,811.00
2014-06-30$364,109.00$0.00$364,109.00
2013-09-30-$75,184.00
2013-06-30-$31,946.00
2012-09-30-$71,995.00
2012-06-30-$55,957.00
2011-09-30-$38,954.00
2011-06-30-$80,620.00$85.00-$80,705.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-06-30-$405,168.00
2024-06-30-$935,118.00
2023-06-30-$1.11M
2022-06-30-$1.44M
2021-06-30-$1.15M
2020-06-30-$1.85M
2019-06-30-$2.06M$2,874.00-$2.06M
2018-06-30-$2.18M
2017-06-30-$2.05M
2016-06-30-$4.5M$9,879.00-$4.51M
2015-06-30-$1.43M$3,901.00-$1.43M
2014-06-30$226,442.00$0.00$226,442.00
2013-06-30-$128,647.00
2012-06-30-$170,278.00
2011-06-30-$1.4M$3,506.00-$1.4M